“…To our knowledge, the most studied and understood mitophagy pathway is mediated by PTEN-induced kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin (Narendra et al, 2008;Vives-Bauza et al, 2010), both of which have been linked to forms of Parkinson's disease (Kitada et al, 1998;Valente et al, 2004). The complicated mechanisms of canonical and non-canonical PINK1/parkinmediated mitophagy have been well summarized in previous reviews (Eiyama and Okamoto, 2015;Lazarou et al, 2015;Nguyen et al, 2016;Clark et al, 2020;Malpartida et al, 2020). Moreover, two main types of receptor-mediated mitophagy pathway have been classified as follows in brief: ubiquitinindependent mitophagy receptors, including BCL2-interacting protein 3 (BNIP3) (Quinsay et al, 2010), BCL2-interacting protein 3 like (NIX/BNIP3L) (Sandoval et al, 2008), FUN14 domain-containing 1 (FUNDC1) (Liu et al, 2012), BCL2-like 13 (BCL2L13) (Otsu et al, 2015), autophagy and beclin 1 regulator 1 (AMBRA1) (Strappazzon et al, 2015), FKBP prolyl isomerase 8 (FKBP8) (Bhujabal et al, 2017), prohibitin 2 (PHB2) (Wei et al, 2017), and NLR family member X1 (NLRX1) (Zhang et al, 2019); lipid-mediated mitophagy receptors, including ceramide (Sentelle et al, 2012) and cardiolipin (Li et al, 2015).…”